trichlormethiazide has been researched along with ADPKD in 1 studies
Trichlormethiazide: A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p830)
trichlormethiazide : A benzothiadiazine, hydrogenated at positions 2, 3 and 4 and substituted with an aminosulfonyl group at C-7, a chloro substituent at C-6 and a dichloromethyl group at C-3 and with S-1 as an S,S-dioxide. A sulfonamide antibiotic, it is used as a diuretic to treat oedema (including that associated with heart failure) and hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The vasopressin V2 receptor antagonist tolvaptan delays the progression of autosomal dominant polycystic kidney disease (ADPKD)." | 5.41 | The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial. ( Ishibashi, Y; Kitayama, C; Uchiyama, K; Yanai, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uchiyama, K | 1 |
| Kitayama, C | 1 |
| Yanai, A | 1 |
| Ishibashi, Y | 1 |
1 trial available for trichlormethiazide and ADPKD
| Article | Year |
|---|---|
The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Cross-Over Studies; Drug Therapy, Combinatio | 2021 |